PsychedelicNewsBreaks – Rritual Superfoods Inc.’s ‘Stamp of Approval’ Reinforces Product Distinction

December 4, 2020 13:32:32

Rritual, a plant-based consumer brand, is a private company that manufactures premium products including small-batch elixir powders and premium shots made from medicinal mushrooms and adaptogenic herbs. With a mission to help people meet the demands of modern life with style and ease through mushroom adaptogen products, Rritual stands distinct among other brands. A recent article discussing this reads, “Rritual was selected as the runner up for the Buyers Choice Award for its Reishi Relax Elixir, picked by retail buyers from dozens of entries. ‘Retail buyers selected Rritual for the award because our packaging, design and formulation stood out amongst the dozens of products they evaluated,’ CEO David Kerbel said. ‘Their stamp of approval on our product reinforces what we know: that Rritual products will capture the attention of shoppers on shelves and in e-comm, supporting our anticipated year-one growth.’”

To view the full article, visit

About Rritual Superfoods Inc.

Rritual is a plant-based consumer wellness brand dedicated to creating simple, pure, yet effective plant-based health products that are mindfully designed to also facilitate the practice of daily self-care, so that the health of the whole body, mind & spirit is supported. Backed by a leading team of scientists, doctors, nutritionists, and experts across the wellness space, Rritual has entered the market with their flagship collection of certified organic Mushroom and Adaptogen Elixir Mix powders, offering products made with the most-popular mushrooms and in the top need-state health categories: Lion’s Mane FocusReishi Relax, and Chaga Immune. For more information, visit the company’s website at or visit TwitterInstagramLinkedIn and Facebook.

NOTE TO INVESTORS: The latest news and updates relating to Rritual are available in the company’s newsroom at

About PsychedelicNewsWire

PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.

To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)

For more information please visit

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published:

Do you have questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California
415.949.5050 Office

PsychedelicNewsWire is part of the InvestorBrandNetwork.